Nuveen Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
$423M Buy
1,051,111
+261,891
+33% +$105M 0.12% 146
2024
Q3
$367M Sell
789,220
-15,130
-2% -$7.04M 0.1% 165
2024
Q2
$377M Sell
804,350
-31,367
-4% -$14.7M 0.11% 146
2024
Q1
$349M Sell
835,717
-5,406
-0.6% -$2.26M 0.1% 170
2023
Q4
$342M Buy
841,123
+28,536
+4% +$11.6M 0.11% 165
2023
Q3
$283M Sell
812,587
-39,405
-5% -$13.7M 0.1% 182
2023
Q2
$300M Sell
851,992
-56,336
-6% -$19.8M 0.1% 166
2023
Q1
$286M Sell
908,328
-1,703
-0.2% -$537K 0.11% 175
2022
Q4
$263M Sell
910,031
-424,810
-32% -$123M 0.1% 191
2022
Q3
$386M Buy
1,334,841
+82,937
+7% +$24M 0.16% 130
2022
Q2
$353M Sell
1,251,904
-5,830
-0.5% -$1.64M 0.14% 142
2022
Q1
$315M Sell
1,257,734
-86,100
-6% -$21.5M 0.1% 187
2021
Q4
$295M Sell
1,343,834
-21,391
-2% -$4.7M 0.09% 212
2021
Q3
$248M Sell
1,365,225
-1,441,437
-51% -$261M 0.08% 233
2021
Q2
$566M Buy
2,806,662
+63,271
+2% +$12.8M 0.17% 118
2021
Q1
$590M Buy
2,743,391
+121,953
+5% +$26.2M 0.19% 110
2020
Q4
$620M Sell
2,621,438
-880,517
-25% -$208M 0.21% 98
2020
Q3
$953M Buy
3,501,955
+23,572
+0.7% +$6.41M 0.37% 58
2020
Q2
$1.01B Buy
3,478,383
+726,720
+26% +$211M 0.41% 49
2020
Q1
$655M Buy
2,751,663
+238,591
+9% +$56.8M 0.32% 69
2019
Q4
$550M Buy
2,513,072
+445,821
+22% +$97.6M 0.21% 103
2019
Q3
$350M Sell
2,067,251
-240,152
-10% -$40.7M 0.14% 144
2019
Q2
$423M Buy
2,307,403
+2,292,058
+14,937% +$420M 0.17% 123
2019
Q1
$2.82M Sell
15,345
-3
-0% -$552 0.02% 596
2018
Q4
$2.54M Sell
15,348
-108
-0.7% -$17.9K 0.02% 588
2018
Q3
$2.98M Sell
15,456
-490
-3% -$94.4K 0.02% 601
2018
Q2
$2.71M Sell
15,946
-2,375
-13% -$404K 0.02% 578
2018
Q1
$2.99M Sell
18,321
-9,076
-33% -$1.48M 0.02% 542
2017
Q4
$4.11M Sell
27,397
-61,138
-69% -$9.16M 0.03% 487
2017
Q3
$13.5M Sell
88,535
-31,684
-26% -$4.82M 0.09% 328
2017
Q2
$15.5M Buy
120,219
+53,439
+80% +$6.89M 0.1% 307
2017
Q1
$7.3M Buy
66,780
+10,093
+18% +$1.1M 0.04% 473
2016
Q4
$4.18M Sell
56,687
-125,609
-69% -$9.25M 0.02% 669
2016
Q3
$15.9M Buy
182,296
+24,658
+16% +$2.15M 0.09% 258
2016
Q2
$13.6M Buy
157,638
+141,721
+890% +$12.2M 0.08% 291
2016
Q1
$1.27K Sell
15,917
-249
-2% -$20 0.01% 929
2015
Q4
$2.03K Sell
16,166
-892
-5% -$112 0.01% 761
2015
Q3
$1.78K Buy
17,058
+636
+4% +$66 0.01% 795
2015
Q2
$2.03K Sell
16,422
-29,355
-64% -$3.63K 0.01% 803
2015
Q1
$5.4M Sell
45,777
-65,937
-59% -$7.78M 0.03% 510
2014
Q4
$13.3M Sell
111,714
-127,854
-53% -$15.2M 0.07% 330
2014
Q3
$26.9M Buy
239,568
+41,928
+21% +$4.71M 0.17% 156
2014
Q2
$18.7M Buy
197,640
+160,450
+431% +$15.2M 0.11% 247
2014
Q1
$2.63M Sell
37,190
-548
-1% -$38.8K 0.02% 675
2013
Q4
$2.8M Sell
37,738
-14
-0% -$1.04K 0.02% 618
2013
Q3
$2.86M Sell
37,752
-64,097
-63% -$4.86M 0.02% 604
2013
Q2
$8.15M Buy
+101,849
New +$8.15M 0.05% 376